treatment guidelines

Research in Review

Immunotherapy Drug Improves Overall Survival in Patients With NSCLC

12/30/2015

JCP Editors

Favorable results for pembrolizumab, a PD-1/PD-L1 inhibitor only recently approved for the treatment of non-small-cell lung cancer (NSCLC), were found in a trial comparing the drug’s effectiveness to that of the...

...

12/30/2015

Journal of Clinical Pathways

Research in Review

Earlier Chemotherapy Improves Outcomes for Patients With Prostate Cancer

12/30/2015

JCP Editors

Results from a recent clinical trial have shown that earlier chemotherapy treatment may lead to improved outcomes for prostate cancer patients initiating long-term hormone therapy. A paper published in Lancet...

...

12/30/2015

Journal of Clinical Pathways

Research in Review

Patient-Centered Approach to Cancer Treatment Decisions Lacking for Older Adults, New Study Shows

12/28/2015

JCP Editors

A new study sheds light on the factors that shape cancer treatment decisions for older adult patients with complex health and social care needs. Researchers from the University of Southampton, UK, led by Jackie...

A new...

12/28/2015

Journal of Clinical Pathways

Research in Review

Five-Factor Risk Assessment Identifies Patients Who Most Benefit from Bevacizumab Treatment

12/23/2015

JCP Editors

Cervical cancer patients categorized as mid- or high-risk using the Moore criteria can benefit from adding bevacizumab to their chemotherapy regimen, according to a new study published in Clinical Cancer Research....

...

12/23/2015

Journal of Clinical Pathways

Fewer Palliative Radiotherapy Treatments for Bone Metastases Shorten Hospital Stays Without Sacrificing Pain Relief

12/18/2015

JCP Editors

Fewer radiation treatments for bone metastases in patients with stage IV or incurable cancer can improve patient care while reducing the length of hospital stay, according to a study presented at the Palliative Care...

Fewer...

12/18/2015

Journal of Clinical Pathways

Interview

A Clinical Pathway for Transcatheter Aortic Valve Replacement

12/14/2015

More and more, various health care institutions around the country are implementing clinical pathways in an effort to improve outcomes and control costs. A 2003 study reported that more than 80% of hospitals had implemented clinical...

More and more, various...

12/14/2015

Journal of Clinical Pathways

Interview

Evidence Blocks to Evaluate the Relative Value of Oncology Treatments

12/14/2015

Many institutions and health care professionals have been aware of the staggering rise of health care costs. An IMS Health report published in May of 2015 confirmed that drug sales in the United States surpassed $100...

Many...

12/14/2015

Journal of Clinical Pathways

Research in Review

ASCO Updates Antiemetic Guidelines to Include New Agent

12/11/2015

JCP Editors

The American Society of Clinical Oncology (ASCO) issued updated antiemetic guidelines recommending that patients who receive highly emetogenic chemotherapy regimens be offered a 3-drug combination of a neurokinin 1...

The...

12/11/2015

Journal of Clinical Pathways

Research in Review

SYNTAX Guides Decision-Making for Myocardial Revascularization

12/11/2015

JCP Editors

Gauging a patient’s candidacy for percutaneous coronary intervention (PCI) versus coronary artery bypass graft (CABG) surgery has gotten easier as a result of the SYNTAX (SYNergy between Percutaneous Coronary...

...

12/11/2015

Journal of Clinical Pathways

Research in Review

Patients Deferring Aggressive Treatment for Prostate Cancer Not Being Monitored Appropriately

12/04/2015

JCP Editors

Patients choosing surveillance over aggressive treatment for prostate cancer are not being monitored as closely as they should be, according to a new study published by a team of University of California, Los Angeles...

...

12/04/2015

Journal of Clinical Pathways